Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENSET - GENXY -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (5)	7/11/1999 6:01:00 PM
From: Walkingshadow	Read Replies (2) \| Respond to of 200

Thanks for the post; very helpful. They would appear to be pursuing a different strategy towards obesity compared to MLNM, targeting peripheral mechanisms rather than central. Any products ultimately developed employing such an approach might not necessarily be in direct competition with MLNM's approach, and could even be synergistic, so it might be oversimplified to view this company to be in direct competition, in the usual sense, with MLNM. Have you seen the JBC publication referred to in the release? Regards, Walkingshadow